How to reignite the fight against the nation’s opioid epidemic
The COVID-19 crisis is far from over, yet the opioid epidemic continues to flare. The AMA details steps states should take, and calls on CDC to revise its opioid prescribing guideline.
Prioritizing Equity video series: COVID-19 & Asian American & Pacific Islander Voices [postponed]
Explore the ways COVID-19 may uniquely impact Asian American and Pacific Islander communities during the latest installment of our YouTube health equity series.
AMA COVID-19 daily video update: Experts discuss the pandemic’s impact on the opioid epidemic
The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.
Taking action on opioid use disorder, pain & harm reduction during COVID-19
Updated July 2, 2020
New policies on treating pain, OUD emerge from COVID-19 crisis
The DEA is allowing qualified physicians to prescribe buprenorphine over the telephone so patients can stay home. The AMA urges states to do the same.
AMA urges governors to adopt DEA guidance for opioid use disorder
This guidance removes a considerable barrier for many patients during the COVID-19 national emergency and, importantly, allows them to stay at home.
COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights